BioSupply Trends Quarterly logo
Subscribe
Winter 2013 - Plasma
  Download Issue
Share

Up Front

Publisher's Corner
Plasma Therapies: From Supply to Dosing and Reimbursement
By Patrick M. Schmidt

Features

When It Turns Out to Be Primary Immunodeficiency Disease: Benefits of Early Diagnosis

Immune Globulin: A Guide to Billing and Reimbursement

Myths and Facts: Hepatitis C

Cancer: The New Chronic Illness

Research Developments for Multiple Sclerosis

BioTrends Watch

Washington Report
New Tools to Help Decipher Health Benefits
HHS Announces Program for Mental Health Disorders
Secure Health Information Sharing Demonstration a Success
New Bill Will Modify Medical Loss Ratios
Office of Mobile Health to Speed Up Medical App Approval
6M Uninsured Americans to Be Hit with Tax Penalty
Reimbursement FAQs
Reimbursement FAQs
Industry News
CSL Wins U.S. Government Contract for Flu Vaccines
Experimental Prostate Cancer Vaccine Shows Promise
Meningitis B Vaccine Shows Promise
Third Dose of MMR Vaccine May Help to Control Mumps Outbreak
Pertussis Vaccine Loses Power Over Time
Immunoglobulin Nursing Society Holds First National Conference
Baxter Receives FDA Approval for Advate 4000 IU
Flu and Fever in Pregnancy Is Linked to Autism Risk
Niacin Could Stop Spread of MRSA
CDC Preparing Vaccine for New Swine Flu
Swine Flu Vaccine May Protect Against Other Flu Viruses
Scientists Closer to a Universal Flu Vaccine
Vaccine to Prevent Premature Birth May Be Possible
Vitamin D Activates Immune Response to TB
People and Places in the News
48,000 Preventable Deaths in 2011 Due to Lack of Insurance
Scientists Discover How/When Infection Triggers Autoimmune Disorders

BioFocus

Industry Insight
The Plasma Industry: Investing Today to Ensure IG and Albumin Supply for Tomorrow
By Keith Berman, MPH, MBA
Patient Profile
XLA: A Patient's Perspective
By Trudie Mitschang
Physician Profile
XLA: A Physician's Perspective
By BSTQ Staff

BioSources

BioResearch
IVIG as Effective as Plasma Exchange in Treating Guillain Barré Syndrome
Study Shows New SCIG Drug Evogam Safe and Efficacious
Study Reveals Clinical Manifestations that Lead to Delayed Diagnosis in CVID Patients